SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Frasier W. Brickhouse II, Vice President, Chief Financial Officer and Treasurer, notified the Company on July 28, 2026 of his intention to retire effective September 1, 2026, after more than 30 years of service. The departure of a CFO is material to investors as it affects financial stewardship and internal controls.
View raw filing on EDGAR →Ares Management Corporation disclosed Q2 2026 financial results, including GAAP net income of $150.6 million, earnings per share of $0.49, $671.3 billion in AUM, and $36.4 billion in fundraising. The earnings announcement was made via press release and presentation materials furnished under Items 2.02 and 7.01.
View raw filing on EDGAR →nVent Electric plc issued a press release on July 31, 2026 announcing Q2 2026 earnings results, including reported sales of $1.5 billion (up 53%), reported EPS of $1.32 (up 103%), and adjusted EPS of $1.45 (up 69%), along with significantly raised full-year 2026 guidance. The filing explicitly states "On July 31, 2026, nVent Electric plc (the "Company") issued a press release announcing earnings results for the second quarter of 2026," with the press release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →This press release announces that SiEngine Technology Co., Ltd., ECARX's largest-held affiliate investment, has secured US$200 million in new equity capital from institutional investors in H1 2026. While the financing is technically raised by the affiliate (not ECARX directly), the disclosure emphasizes that this validates "ECARX's long-term vertical integration strategy" and strengthens the "unique ECARX vertical silicon-to-software competitive moat." The event is material to ECARX shareholders as it affects the value and strategic importance of a flagship affiliate holding, but it does not fit neatly into the discrete event categories (not M&A, not a debt issuance by ECARX itself, not a dilutive issuance by ECARX). It is a significant financial development affecting an equity investment, best classified as `financial_other`.
View raw filing on EDGAR →Kyivstar Group announced financial and operating results for the second quarter and half-year ended June 30, 2026, reporting revenue of USD 339 million (+19.3% YoY), EBITDA of USD 188 million (+13.7%), and net profit of USD 77 million, with raised 2026 guidance for both revenue and EBITDA.
View raw filing on EDGAR →AutoNation issued a press release on July 31, 2026 announcing its results of operations for the fiscal quarter ended June 30, 2026, disclosing Q2 2026 EPS of $5.39 and Adjusted EPS of $5.56, along with detailed financial statements and operational metrics. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is the designated Item for disclosure of results of operations and financial condition.
View raw filing on EDGAR →T. Rowe Price Group issued an earnings release on July 31, 2026 reporting results of operations for the three and six months ended June 30, 2026. The disclosure includes comprehensive financial highlights with diluted EPS of $2.88 (U.S. GAAP) and $2.57 (adjusted), AUM of $1.9 trillion, net client outflows of $6.5 billion, and detailed breakdowns of revenues, operating expenses, and non-operating income. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 filed on July 31, 2026. The Item 2.02 disclosure explicitly states "Cboe Global Markets, Inc. (the 'Company') reported its financial results for the quarter ended June 30, 2026" with the press release attached as Exhibit 99.1. The press release contains detailed financial results including diluted EPS of $3.35 (up 50%), record net revenue of $731.6 million (up 25%), and updated 2026 guidance, all of which are material to investors' assessment of the company's financial performance.
View raw filing on EDGAR →Gates Industrial disclosed its second-quarter 2026 financial results on July 31, 2026, including net sales of $941.6 million (up 6.6% YoY), net income of $170.9 million ($0.67 per diluted share), and Adjusted EBITDA of $211.4 million. The company also raised its full-year 2026 guidance for sales, profitability, and adjusted EPS. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, with material financial results and forward guidance that would affect investor assessment of the company's performance.
View raw filing on EDGAR →This is a straightforward earnings release for Q2 2026. The Item 2.02 disclosure announces second quarter 2026 financial results (net income of $27.4 million, EPS of $2.55, revenue of $454.9 million), with the full press release furnished as Exhibit 99.1. The filing explicitly states "Oppenheimer Holdings Inc. Reports Second Quarter 2026 Earnings" and provides detailed consolidated income statements, segment results, and management commentary on operating performance.
View raw filing on EDGAR →IRADIMED issued a press release on July 31, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing revenue of $20.5 million, GAAP diluted EPS of $0.41, and non-GAAP diluted EPS of $0.46 for Q2 2026, along with reaffirmed full-year 2026 guidance and a declared quarterly cash dividend of $0.20 per share. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →Moog Inc. reported record third-quarter 2026 results (quarter ended June 27, 2026) with net sales of $1.117 billion (15% increase) and record adjusted EPS of $3.72 (60% increase), along with expanded operating margins. The company raised full-year 2026 guidance across all key metrics.
View raw filing on EDGAR →Moog Inc.'s Board declared a quarterly dividend of $0.30 per share on both Class A and Class B common stock, payable on August 25, 2026 to shareholders of record as of August 14, 2026.
View raw filing on EDGAR →Douglas J. Williamson, M.D. was appointed as a director to Vistagen's Board of Directors, effective July 29, 2026. Dr. Williamson brings nearly three decades of neuroscience drug development and regulatory expertise, including prior roles as Chief Medical Officer and executive positions at major pharmaceutical firms, strengthening the board's clinical and development capabilities.
View raw filing on EDGAR →The filing discloses a declaration of distributions to stockholders across multiple share classes (Class I, D, T, E, and Y common stock) with specific per-share amounts and payment dates. This is a routine but material dividend distribution event typical of real estate investment trusts (REITs), which are required to distribute substantially all taxable income to shareholders. The disclosure includes gross distributions, applicable servicing fees, net distributions per share, record date, and payment date of August 5, 2026.
View raw filing on EDGAR →The filing discloses a declaration of distributions to shareholders across five classes of common shares, with a gross distribution of $0.1700 per share (comprising $0.1350 regular and $0.0350 special distribution) payable on or about August 20, 2026. This is a routine but material dividend declaration typical of a real estate investment trust (REIT), affecting shareholder returns and capital allocation.
View raw filing on EDGAR →Roberto Stanichi was promoted to President, Chief Marketing and Brand Officer on July 29, 2026, a material elevation in role and responsibility within Mattel's executive leadership. The promotion includes compensatory arrangements with a base salary of $900,000 and stock grants totaling $3.9 million, and represents a significant governance event affecting the company's leadership structure.
View raw filing on EDGAR →Greif issued a press release on July 28, 2026, announcing financial results for its third quarter ended June 30, 2026, including net income of $78.8 million (up 156.7%), Adjusted EBITDA of $183.4 million (up 24.7%), segment-level results, and forward guidance.
View raw filing on EDGAR →The Board declared a quarterly cash dividend of $0.20 per share payable on August 25, 2026. This is a routine but material capital allocation decision that affects shareholder returns and is a standard disclosure under Item 8.01 for dividend declarations.
View raw filing on EDGAR →DocGo received notice from Nasdaq on July 28, 2026 that it has failed to satisfy the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and has been granted an additional 180 calendar days (until January 25, 2027) to regain compliance. The disclosure explicitly addresses failure to satisfy a continued listing rule and the risk of delisting if the stock price does not recover to at least $1.00 per share for 10 consecutive business days. This is a material event that directly threatens the company's continued listing status.
View raw filing on EDGAR →Context Therapeutics received written notice from Nasdaq on July 29, 2026, that it failed to maintain the minimum closing bid price of $1.00 per share for 30 consecutive business days, triggering non-compliance with Nasdaq Listing Rule 5550(a)(2). The company has until January 25, 2027, to regain compliance or faces potential delisting, with the possibility of a second 180-day cure period if it meets Capital Market listing standards. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 28, 2026, covering three proposals: election of directors (Susan L. Blount, Bill C. Boor, and Lisa L. Daniels), advisory approval of named executive officer compensation, and ratification of RSM US LLP as independent auditor. The filing directly addresses Item 5.07 requirements and reports final vote tallies for each proposal, making this a textbook shareholder_vote_results event that is material to investors assessing governance and board composition.
View raw filing on EDGAR →This press release discloses the final voting results from ICON plc's Annual General Meeting held on July 31, 2026, including detailed vote tallies for all eight resolutions (director elections, account approval, auditor remuneration authorization, share allotment authority, and share repurchase authorization). The disclosure directly matches the shareholder_vote_results category, which covers results of votes at annual or special meetings of security holders. All resolutions passed, including the election of new directors Barry Balfe, Kevin Egan, and Jeff Elliott, and the re-election of existing directors.
View raw filing on EDGAR →The Item 8.01 disclosure centers on two material events: (1) a $54.6M ten-year contract award (operational/strategic), and (2) a warrant inducement transaction involving $4.5M in gross proceeds and issuance of 5,012,159 new unregistered warrants at 150% of exercised warrants. The warrant issuance is a dilutive equity transaction requiring shareholder approval, fitting the dilutive_issuance category. While the contract award is also material, the warrant transaction is the more legally and financially significant disclosure requiring 8-K Item 8.01 treatment as an "other event."
View raw filing on EDGAR →Healthcare Realty Trust filed a new automatic shelf registration statement and prospectus supplement on July 31, 2026, establishing an at-the-market (ATM) equity offering program with an aggregate gross sales price of up to $1,000,000,000 in Class A common stock. The filing of an ATM prospectus supplement with a substantial offering capacity represents a material dilutive issuance event, as it creates the mechanism for future equity sales that could dilute existing shareholders. The $1 billion offering capacity is material to a REIT of this size.
View raw filing on EDGAR →Lloyds Banking Group announces commencement of a £1 billion share buyback programme, with Goldman Sachs International as broker and an end date of 27 January 2027. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The £1 billion scale and explicit statement that "the sole purpose of the programme is to reduce the ordinary share capital" make this material to investors assessing capital allocation and shareholder returns.
View raw filing on EDGAR →HSBC has agreed to sell its AUD36 billion (US$25 billion) Australian home and personal loan portfolio to Blackstone-affiliated Virgo BidCo Pty Ltd. This is a material disposition of a substantial asset portfolio, disclosed as a "disclosable transaction" under Hong Kong Listing Rules Chapter 14. The transaction includes associated restructuring costs of US$0.3 billion and wind-down of HSBC Australia's retail business, representing a significant strategic realignment of HSBC's Australian operations.
View raw filing on EDGAR →This 6-K discloses European Commission approval of Datroway (datopotamab deruxtecan) for first-line treatment of metastatic triple-negative breast cancer, a significant regulatory milestone for AstraZeneca's oncology portfolio. The approval is based on positive Phase III trial results (TROPION-Breast02) showing statistically significant overall survival and progression-free survival benefits. While not a discrete M&A transaction, earnings release, or executive change, this regulatory approval of a marketed pharmaceutical product represents a material operational and commercial milestone that would affect a reasonable investor's assessment of the company's pipeline progress and market opportunities in oncology.
View raw filing on EDGAR →Linde plc issued a press release on July 31, 2026 disclosing second-quarter 2026 financial results, including sales of $9.3 billion (up 9% YoY), operating profit of $2.6 billion, diluted EPS of $4.15 (up 11%), and full-year 2026 adjusted EPS guidance of $17.70–$17.90. This is a standard quarterly earnings release filed under Item 2.02 with detailed segment results and forward guidance, materially affecting investor assessment of the company's financial performance and outlook.
View raw filing on EDGAR →This is NatWest Group plc's interim financial report for the first half of 2026 (H1 2026), covering the period ended 30 June 2026. The document contains condensed consolidated financial statements (income statement, balance sheet, cash flow statement, statement of changes in equity), detailed segment performance analysis, capital and risk management disclosures, and management commentary. The filing explicitly states "Interim Results 2026" and includes full financial statements and notes characteristic of a periodic interim report, not a discrete earnings announcement or event. This is the foreign-issuer equivalent of a 10-Q interim report.
View raw filing on EDGAR →This is NatWest Group plc's interim financial report for the half-year ended 30 June 2026, comprising condensed consolidated financial statements (income statement, comprehensive income, balance sheet, changes in equity, and cash flow statement) prepared in accordance with IAS 34 Interim Financial Reporting. The document explicitly states it is "INTERIM RESULTS 2026 - PART 2" and includes unaudited interim financial statements with comparative periods. This is a periodic interim report, not a discrete event or earnings release announcement.
View raw filing on EDGAR →BP announces the conclusion of a formal audit tender process and the Board's confirmation of Deloitte LLP's re-appointment as statutory auditor effective from the 2028 financial year, subject to shareholder approval at the 2027 AGM. Although technically a re-appointment rather than a change to a new auditor, this disclosure follows a formal competitive tender process required by applicable legislation every 10 years, and represents a material governance decision affecting the registrant's independent audit function.
View raw filing on EDGAR →This 6-K discloses grants of Global Long-Term Incentive (GLTI) performance shares and Market Value Share Options (MVSO) to nine Persons Discharging Managerial Responsibilities (PDMRs) on 30 July 2026, including the CEO, CFO, and other senior executives. The disclosure is made under DTR 3.1.2-A (Market Abuse Regulation Article 19) and details conditional equity awards with performance conditions tied to Free Cash Flow and ESG targets. This is a compensatory arrangement for named executives and would materially affect investor assessment of executive incentive structures.
View raw filing on EDGAR →This is Pearson's interim financial report for the six months ended 30 June 2026, containing unaudited condensed consolidated financial statements and detailed operational review. The document presents H1 2026 revenue (£1,779m), adjusted operating profit (£276m), free cash flow (£259m), and forward guidance for full-year 2026. As a periodic interim report (the foreign-issuer equivalent of a 10-Q), it should be classified as `periodic_interim` rather than `earnings_release`, which is reserved for discrete press releases announcing results.
View raw filing on EDGAR →The filing discloses a declaration of distributions across multiple share classes of Blackstone Real Estate Income Trust, Inc., with specific per-share amounts ranging from $0.0451 to $0.0557 (net of servicing fees). The distributions are payable to stockholders of record as of July 31, 2026, and will be paid on or about August 20, 2026. This is a routine but material dividend distribution disclosure typical of REITs, which are required to distribute substantially all taxable income to shareholders.
View raw filing on EDGAR →This is a press release announcing Fortis Inc.'s second quarter 2026 financial results, disclosing net earnings of $396 million ($0.78 per share), year-to-date earnings of $897 million, and capital expenditure updates. The document explicitly states "FORTIS INC. RELEASES SECOND QUARTER 2026 RESULTS" and includes detailed financial performance metrics, capital plan progress, and forward-looking guidance—all hallmarks of an earnings release that would materially affect a reasonable investor's assessment of the registrant's financial performance and prospects.
View raw filing on EDGAR →The 6-K furnishes Exhibit 99.1, an "Investor Presentation: Q2 2026 Earnings Conference Call" dated July 31, 2026. This is a discrete earnings presentation accompanying a quarterly results announcement, not a periodic financial report. The exhibit is material to investors assessing the registrant's quarterly financial performance and forward guidance.
View raw filing on EDGAR →HF Foods entered into Joinder and Amendment No. 7 to its credit agreement on July 29, 2026, increasing the revolving credit facility from $125 million to $140 million and adding approximately $40.1 million in new term loan advances, resulting in total term loans of $125 million. This amendment materially increases the company's debt capacity and outstanding indebtedness.
View raw filing on EDGAR →Moderna issued a press release on July 31, 2026 announcing its second quarter 2026 financial results, including revenue of $145 million, GAAP net loss of $(0.8) billion, and GAAP EPS of $(1.97). The filing includes condensed consolidated financial statements (income statement, balance sheet, and cash flow statement) and updated 2026 financial guidance. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →This is a notification of a relevant change to a significant shareholder under AIM Rules. BlackRock, Inc. crossed a notification threshold on July 28, 2026, increasing its total voting rights from 6.18% to 7.10% (988,271 direct shares plus 189,690 from securities lending and 196,701 from CFDs). While not a traditional governance event like an executive appointment or board change, this disclosure of a major shareholder crossing a regulatory threshold is a governance matter affecting control and voting structure that would be material to investors assessing the registrant's shareholder base and potential influence.
View raw filing on EDGAR →Aethlon Medical effectuated a 1-for-5 reverse stock split on July 30, 2026, reducing authorized shares from 100 million to 20 million and outstanding shares from approximately 3.25 million to approximately 650,000. The reverse split modifies the rights and structure of common stockholders and affects trading symbol adjustments and Nasdaq listing rule compliance.
View raw filing on EDGAR →The Compensation Committee granted equity awards totaling 100,000 shares under the 2024 Equity Incentive Plan on July 29, 2026, with 85,000 shares distributed to three named officers (CEO Shufang Gao receiving 45,000 shares, CFO Wei Fang receiving 20,000 shares, and VP Ying Deng receiving 20,000 shares). This is a direct disclosure of compensatory arrangements—equity grants to executives—which is the core definition of exec_compensation under Item 5.02(e).
View raw filing on EDGAR →The filing discloses termination of a material acquisition agreement for the Apache Creek Golf Course business. Although the transaction did not close, the Company's inability to obtain financing and the resulting loss of a $200,000 deposit represents a material M&A event that would affect investor assessment of the registrant's capital position and strategic plans. Item 1.02 is the designated disclosure item for termination of material definitive agreements related to acquisitions.
View raw filing on EDGAR →The Seoul Central District Court issued a judgment against Franklin Technology Inc. (a subsidiary of Franklin Wireless Corp.) ordering payment of approximately $3.67 million in damages plus interest in a commercial contract dispute with Partron Co., Ltd. This is a material litigation settlement/judgment that would affect a reasonable investor's assessment of the company's financial obligations and legal exposure.
View raw filing on EDGAR →Nocera entered into binding Transaction Agreements on July 28, 2026, to acquire a controlling 30% equity interest in QMAX Technology Co., Ltd. through a VIE structure, involving voting rights proxy, equity pledge, exclusive call option, and exclusive business cooperation agreements, with consideration of 300,000 restricted shares valued at $408,000. This constitutes a material acquisition representing a strategic entry into the AI infrastructure and memory supply chain sector.
View raw filing on EDGAR →Nocera received notice of default on a senior secured convertible promissory note dated July 27, 2026, triggered by failure to pay $6,029,495 in Alternate Conversion Floor Amounts due under the Note. This event of default caused the Collateral Agent to exercise control over pledged collateral, with the Company remaining liable for approximately $1,370,809 after partial satisfaction.
View raw filing on EDGAR →Nocera regained compliance with Nasdaq Listing Rule 5550(a)(2) following a minimum bid price deficiency, having previously failed to maintain the $1.00 minimum closing bid price (notified February 2, 2026). The July 28, 2026 Compliance Notice confirms the company satisfied the 15 consecutive business days requirement and Nasdaq has closed the matter.
View raw filing on EDGAR →Nixxy terminated its binding Letter of Intent with Tachyon 9 Corporation dated June 15, 2026, and is pivoting its M&A strategy to pursue direct negotiations with the Nakota project developer for a long-term definitive agreement to acquire the entire project, representing a material shift in the company's acquisition strategy and capital allocation priorities.
View raw filing on EDGAR →Cannae Holdings sold its entire ownership interest in Watkins Holdings, LLC for $90 million in cash proceeds. This is a material asset disposition and capital redeployment event that affects the company's portfolio composition and liquidity. While the sale could be characterized as a divestiture or asset sale, it does not rise to the level of a "material acquisition, disposition, merger, or change of control" under ma_activity (which typically applies to transactions material enough to trigger Item 1.01 or 2.01 reporting). The disclosure emphasizes this as part of Cannae's portfolio transformation strategy and capital redeployment, making it a significant financial event that would affect investor assessment of the company's strategic direction and capital allocation.
View raw filing on EDGAR →The WUTC issued an order approving a multi-year rate increase for NW Natural's Washington operations, authorizing $20.1 million in Year 1 revenue increases (effective August 2026), $7.5 million in Year 2, and $7.4 million in Year 3. This is a material regulatory outcome affecting the company's revenue and rate base, but it is fundamentally a favorable regulatory approval rather than a crisis, covenant breach, or other specific event type. The disclosure centers on the operational and financial impact of approved rate recovery, making it an operational/regulatory milestone rather than a financial obligation event (debt_issuance) or other category.
View raw filing on EDGAR →